MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem cells

被引:72
|
作者
Brower, Jeffrey V. [1 ]
Clark, Paul A. [2 ]
Lyon, Will [2 ]
Kuo, John S. [1 ,3 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI 53792 USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol Surg, Madison, WI 53792 USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53792 USA
关键词
Cancer; Cancer stem cells; Glioblastoma; Glioma; MicroRNA; BRAIN-TUMORS; EXPRESSION PROFILES; MALIGNANT GLIOMA; PROLIFERATION; IDENTIFICATION; MIGRATION; MIR-125B; INVASION; GROWTH; TEMOZOLOMIDE;
D O I
10.1016/j.neuint.2014.06.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs represent an abundant class of endogenously expressed 18-25 nucleotide non-coding RNA molecules that function to silence gene expression through a process of post-transcriptional modification. They exhibit varied and widespread functions during normal development and tissue homeostasis, and accordingly their dysregulation plays major roles in many cancer types. Gliomas are cancers arising from the central nervous system. The most malignant and common glioma is glioblastoma multiforme (GBM), and even with aggressive treatment (surgical resection, chemotherapy, and radiation), average patient survival remains less than 2 years. In this review we will summarize the current findings regarding microRNAs in GBM and the biological and clinical implications of this data. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 50 条
  • [11] Dielectric characterization of glioblastoma cancer stem cells
    Bortolozzi, Roberta
    Mariotto, Elena
    Rampazzo, Elena
    Porcu, Elena
    Saada, Sofiane
    Provent, Thomas
    Lalloue, Fabrice
    Pothier, Arnaud
    Viola, Giampietro
    Persano, Luca
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [12] Identification of Cancer Stem Cells in Dog Glioblastoma
    Stoica, G.
    Lungu, G.
    Martini-Stoica, H.
    Waghela, S.
    Levine, J.
    Smith, R., III
    VETERINARY PATHOLOGY, 2009, 46 (03) : 391 - 406
  • [13] Targeting aggressive cancer stem cells in glioblastoma
    Seymour, Tracy
    Nowak, Anna
    Kakulas, Foteini
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [14] Synergistic modulation of microRNAs for treatment of glioblastoma cancer initiating cells
    Ornell, Kimberly
    Yin, Yuan
    Beliveau, Alexander Alexander
    Jain, Anjana
    CANCER RESEARCH, 2015, 75
  • [15] ANASTASIS IN GLIOBLASTOMA, BRAIN CANCER STEM, AND BRAIN STEM CELLS
    Inceboz, Melodi
    Bagca, Bakiye Goker
    Caner, Ayse
    Gunduz, Cumhur
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2021, 5 (01): : 14 - 21
  • [16] Glioblastoma cancer stem cells: Biomarker and therapeutic advances
    Pointer, Kelli B.
    Clark, Paul A.
    Zorniak, Michael
    Alrfaei, Bahauddeen M.
    Kuo, John S.
    NEUROCHEMISTRY INTERNATIONAL, 2014, 71 : 1 - 7
  • [17] Efficacy of rapamycin against glioblastoma cancer stem cells
    M. Mendiburu-Eliçabe
    J. Gil-Ranedo
    M. Izquierdo
    Clinical and Translational Oncology, 2014, 16 : 495 - 502
  • [18] Glioblastoma cancer stem cells: Adaptive or stable phenotype?
    Dirkse, A.
    Golebiewska, A.
    Brons, N. H. C.
    Buder, T.
    Deutsch, A.
    Leite, S.
    Sauvageot, N.
    Senn, S.
    Herold-Mende, C.
    Niclou, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S78 - S78
  • [19] Identifying key regulators of glioblastoma cancer stem cells
    Wang, Tao
    Xie, Xuanhua
    Parada, Luis F.
    CANCER RESEARCH, 2024, 84 (06)
  • [20] Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme
    Cho, Der-Yang
    Lin, Shinn-Zong
    Yang, Wen-Kuang
    Lee, Han-Chung
    Hsu, Den-Mei
    Lin, Hung-Lin
    Chen, Chun-Chung
    Liu, Chun-Lin
    Lee, Wen-Yuan
    Ho, Li-Hui
    CELL TRANSPLANTATION, 2013, 22 (04) : 731 - 739